Shannon John Patrick Jr - Insider Non-Derivative Transactions at Xeris Biopharma Holdings, Inc. (XERS) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Aug 1, 2024, Shannon John Patrick Jr's relationship to Xeris Biopharma Holdings, Inc. (XERS) is Director,Officer (See Remarks), and currently has 2,419,612 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other XERS insiders.

Data Source: SEC.
Shannon John Patrick Jr - Insider Non-Derivative Transactions of XERS Common Stock
Shannon John Patrick Jr - Insider Non-Derivative Transactions at XERS
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Aug 2, 2024 Acquisition -- (Common Stock) 250000 0 2419612
Feb 1, 2024 F -- (Common Stock) 110750 2.46 2148061
Feb 1, 2024 Acquisition -- (Common Stock) 750000 0 2158575
Jan 30, 2024 F -- (Common Stock) 22150 2.66 2258811
Jan 4, 2024 F -- (Common Stock) 40834 2.24 2280961
Nov 18, 2023 P -- (Common Stock) 30769 1.64 1408575
Feb 1, 2023 Acquisition -- (Common Stock) 750000 0 1377806
Feb 1, 2023 F -- (Common Stock) 9880 1.24 2321795
Jan 30, 2023 F -- (Common Stock) 23414 1.26 2331675
Jan 4, 2023 F -- (Common Stock) 41334 1.12 2355089
Feb 1, 2022 F -- (Common Stock) 7497 2.11 2396423
Jan 30, 2022 F -- (Common Stock) 15692 2.11 2403920